Clin2
NCT07601646Possibly a fitRecruiting

New Paste Treatment for Erectile Dysfunction

Erectile Dysfunction (ED)Erectile DysfunctionsErectile Function

Part of Kidney & urinary, Mental health clinical trials.

This trial tests a new alprostadil paste applied inside the urethra (the tube you urinate through) to help men with erectile dysfunction who haven't responded well to pills like Viagra. The goal is to find the right dose that safely improves erections.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
83 people
Ages
21 years to 75 years
Study type
Interventional

Who can take part

  • Diagnosed with erectile dysfunction for at least 3 months, confirmed by a standard questionnaire (IIEF)
  • Tried Viagra or similar pills without success—couldn't get firm enough erections for sex
  • In a steady heterosexual relationship for at least 6 months
  • Willing to use the study medication as directed and take Viagra during the trial
  • No severe heart conditions, recent heart attack or stroke, or spinal cord injury
  • Not taking nitrate medications, testosterone, or certain other drugs

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06768177Enrolling by invitation
Platelet-Rich Plasma for Erectile Dysfunction

This trial tests if injecting platelet-rich plasma (PRP) into the penis can improve erectile function in men who haven't had success with other treatments. It may be an option if you have moderate to severe ED, have tried other therapies, or have had pelvic surgery.

Bari
NCT07391579Recruiting· Phase 4
Daily Cialis Plus On-Demand Viagra for Hard-to-Treat ED

This trial tests if taking one Cialis pill daily and a Viagra pill only when needed works better for men who have tried ED pills before but they didn't help. It aims to find a new way to help men who haven't responded to standard ED treatments.

Al Mansurah, Dakahlia Governorate
NCT07859202Not yet recruiting· Phase 3
Study of a new treatment for men with erectile dysfunction

This study tests a new medicine, W2505, to see if it is safe and effective for men with erectile dysfunction. Participation may help you manage your condition and contribute to research.

Incheon
NCT06839651Not yet recruiting· Phase 1
Stem cell treatment for severe erectile dysfunction

This trial tests a new treatment made from stem cells for men with severe erectile dysfunction that hasn't improved with sildenafil (Viagra). It might help men who also have well-controlled type 2 diabetes.

NCT07783347Not yet recruiting
Platelet-rich plasma and shock wave therapy for erectile dysfunction

This trial tests whether combining platelet-rich plasma (PRP) injections with low-intensity shock wave therapy works better than PRP alone for men with mild to moderate erectile dysfunction. PRP uses your own blood to help healing, and shock waves may improve blood flow to the penis.

Banhā, Qalyubia Governorate
NCT07231185Not yet recruiting· Phase 2
Sildenafil for erectile dysfunction in adult men

This study tests a new form of sildenafil (the active ingredient in Viagra) for treating erectile dysfunction in men. It aims to see how well it works and how safe it is, and you'll need to track your progress using a smartphone app.

Hear when a new Erectile Function trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.